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Depression is common following acute coronary syndrome (ACS), with shared risk factors including social exposures, such as stressful life events (SLEs) and social support deficits (SSDs) – associated with depression [1], ACS [2], and their comorbidity [3]. The serotonin transporter gene-linked promoter region (5-HTTLPR) s/l polymorphism may modulate the association between psychosocial risk factors and depression, the s allele decreasing 5-HTT expression and increasing depression susceptibility to SLEs [4] and SSDs [5]. To our knowledge, this has not been investigated longitudinally for depression following ACS.

We consecutively recruited 1,152 patients from 2006 to 2013 who were hospitalized at the Department of Cardiology, Chonnam National University Hospital (CNUH), Gwangju, South Korea within 2 weeks of ACS; all participants were re-approached 1 year after baseline evaluation to investigate both acute and chronic phases. At both examinations, depressive disorder diagnoses were determined by the study psychiatrists using the MINI, a structured diagnostic interview for DSM-IV, defining major and minor depressive disorder [6]. From the two evaluations, we defined three binary variables: depressive disorder at baseline, depressive disorder at follow-up in those without depressive disorder at baseline, and depressive disorder at follow-up in those with depressive disorder at baseline. Since ACS patients are usually discharged from hospital within 2 weeks, after intensive medical treatment, criteria applied for depressive disorder diagnosis did not require a 2-week minimum symptom duration at baseline, but required this at follow-up, as is conventional. At baseline, 969 (378 with DSM-IV depressive disorder; 591 without) agreed to phlebotomy and represented the baseline sample. Of these, 711 were successfully followed at 1 year; depressive disorder at follow up was present in 53 (12%) of the 426 who did not have depressive disorder at baseline, and in, 130 (46%) of the 285 who had depressive disorder at baseline. The 258 who were lost to follow-up had significantly older age and higher Killip class (p-values<0.05) than those followed. Written informed consent was collected, and the study was approved by the CNUH Review Board. 

SLEs were defined by the List of Threatening Events, designed to detect events carrying significant threat and of particular salience for depression. [7]. Specifically, the following nine SLEs during the 3 months preceding the acute coronary syndrome were enquired about: serious illness of self (prevalence 16%), serious illness of a close relative (13%), bereavement of a close family member (4%), bereavement of another relative or close friend (10%), marital separation (2%), end of relationship (9%), problem/disagreement with a close friend or relative (11%), severe economic problem (23%), and theft or loss (8%). Positive responses were totaled to generate a summary score, and because of the skewed distribution, were categorized into 2 groups (SLEs absent or present). SSDs were measured by the 6-item Social Support Scale including “someone appreciate what you do” and the 5-item Social Undermining Scale including “someone acted in a unpleasant manner toward you” [8] using 5-point qualifiers (not at all/rarely/occasionally/often/a great deal). Lower scores indicate deficits of social support. Since there is no standard cutoff, summed scale scores were dichotomized at the median into low and high SSD groups. 

5-HTTLPR genotype was determined by polymerase chain reaction (PCR) and PCR-based restriction fragment length polymorphism assays, categorized as ‘l/l,’ ‘l/s,’ or ‘s/s’. Baseline potential covariates comprised sociodemographic data, depression characteristics (personal / family histories of depression), cardiovascular risk factors, and current cardiac status considering previous research [2,3,9]. Patients with and without depressive disorder at baseline were compared using t- or χ2 tests. SLEs, SSDs, and 5-HTTLPR genotypes were compared between groups of patients with and without baseline/follow-up depressive disorders using χ2 tests. To investigate interactive effects, associations of SLEs and SSDs with depressive status were initially stratified by 5-HTTLPR genotype, followed by tests for interactions of SLEs x 5-HTTLPR and SSDs x 5-HTTLPR in multivariate logistic regression models after adjusting for covariates associated with depressive disorder at baseline at p<0.05. All analyses were performed using SPSS 18.0.

Depressive disorder at baseline was significantly (p<0.05) associated with female sex, lower education, living alone, rented housing, current unemployment, hypertension, diabetes, and current smoking, and these were used as covariates in the adjusted analyses. SLEs and high SSDs were significantly associated with all baseline and follow-up depressive disorders (p<0.05). The 5-HTTLPR s allele was significantly associated with baseline depressive disorder and follow-up depressive disorder in those with baseline depressive disorder (p<0.05). Figure 1 presents data for relationships of SLEs and SSDs with depressive disorder status stratified by genotype. The presence of SLEs was significantly associated with baseline depressive disorder in the presence of the s/s genotype; and with follow-up depressive disorder in both baseline groups in the presence of the l/s and s/s genotypes. High SSDs were significantly associated with baseline depressive disorder in the presence of the s/s genotype and with follow-up depressive disorder in those with baseline depressive disorder in the presence of the l/s and s/s genotypes. There were significant interactive effects of SLEs x 5-HTTLPR on baseline depressive disorder [interaction term OR=1.68 (95% CI 1.08-2.64); P=0.032] and of SSDs x 5-HTTLPR on follow-up depressive disorder in those with baseline depressive disorder [OR=1.92 (1.05-3.72); P=0.036] in the adjusted logistic regression models. All analyses were repeated after excluding participants reporting a history of previous depression (N=34), and no substantial differences were found in any models (data not shown).

Our findings confirm the well-documented associations between unfavorable social environments and depression risk, both in patients with ACS [4] and in the general population [1]. Our findings also replicate previous studies in the association between the 5-HTTLPR s allele and depression in ACS [9], and with respect to the interactive effects of genes and environment on depression risk [4,5]. However, our study also presents novel findings with respect to time-specific interactions between social factors and 5-HTTLPR on depression at both acute and chronic phases post-ACS: there was a significant interactive effect of SLEs and 5-HTTLPR on depressive disorder within 2 weeks of ACS and a significant interactive effect of SSDs and 5-HTTLPR on depressive disorder at 1 year in those with baseline depressive disorder. 

These different patterns of genetic-environmental interactions on depression at acute and chronic phases post-ACS may be explained by the nature of unfavorable environments. SLEs are strong risk factors for the onset of depression, but their long-term effects depend on the chronicity of these events [10]. Moreover, acute ACS itself represents a severe life stress when invasive diagnostic and treatment methods are involved. The synergistic effects of SLEs and the 5-HTTLPR s allele on depression may exert a powerful effect in the acute phase of ACS. In contrast, SSDs tend to be stable rather than variable over time, and are therefore well-known predictors of depression persistence [1]. The interaction of SSDs and the 5-HTTLPR s allele on depression may be particularly prominent in the chronic phase of ACS, when general health and functioning become stronger determinants of mood states. However, it is important to bear in mind the single follow-up examination which will not have captured depressive symptom trajectories over 1 year between examinations. Additionally, participants with more severe baseline pathology were more frequently lost to follow-up, which might obscure underlying associations. Moreover, symptoms-duration criteria for depressive disorder at baseline were not standard, although similar criteria have been used in previous evaluations of ACS patients in the acute phase.
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Fig. 1. Depressive disorder status according to stressful life events, social support deficits, and serotonin transporter gene linked promoter region (5-HTTLPR).

Figure legends:
* p-value<0.05; † p-value<0.01; ‡ p-value<0.001 using χ2 tests to test the associations of stressful life events / social support deficits with depressive disorder outcomes for each 5-HTTLPR genotype.
Interactions (Ix.) of SLEs x 5-HTTLPR and SSDs x 5-HTTLPR on depressive status were examined using multivariate logistic regression models after adjusting for gender, education, housing, current employment, hypertension, diabetes, and current smoking for analyses on a) and b), and plus treatment status for analyses on c).




